ConductScience.org, home

Paper36746307

Recent advances in long-acting drug delivery systems for anticancer drug.

Pacheco C and 4 others. Adv Drug Deliv Rev, 2023. Cited by 113 papers, by iCite.

Cite this record

ConductScience Library. Recent advances in long-acting drug delivery systems for anticancer drug. Papers, record 36746307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36746307

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent advances in long-acting drug delivery systems for anticancer drug.
PubMed
Journal
Adv Drug Deliv Rev
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
113
iCite
Relative citation ratio, by iCite
13.8
iCite
Revised in PubMed
2023-04-17
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pacheco CCatarina
2Baião AAna
3Ding TTao
4Cui WWenguo
5Sarmento BBruno

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
NeoplasmsMajor topic
Humans
Drug Delivery Systems
Polymers

Cited by55

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.

PMIDTitleJournalYearIn PapersSource
42797500Therapeutic Resistance in Melanoma: Molecular Mechanisms and Emerging Pharmaceutical Strategies.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42797500PubMed
42653458Thieno[3,2-d]pyrimidines in Anticancer Drug Discovery: Recent Advances in Drug Design and Molecular Targets.Int J Mol Sci2026https://conductscience.org/library/papers/42653458PubMed
42288537Development of surfactin-based nanocarrier for targeted doxorubicin delivery.Sci Rep2026https://conductscience.org/library/papers/42288537PubMed
42177586Transcriptional profiling and functional characterization of the Hc-NHR-49 gene in ivermectin resistance of Haemonchus contortus.Parasit Vectors2026https://conductscience.org/library/papers/42177586PubMed
42130845Biodegradable cross-linked flavone networks featuring either ester or carbamate linkages for controlled delivery of anti-cancer agents.RSC Adv2026https://conductscience.org/library/papers/42130845PubMed
41917675PEGylated Chitosan Nanoparticles: Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment.Cancer Sci2026https://conductscience.org/library/papers/41917675PubMed
41828829Electrospun Fibrous Architectures for Localized Delivery of Photosensitizers in Cancer Therapy.Molecules2026https://conductscience.org/library/papers/41828829PubMed
41767047ATP-sensitive peptide-based coacervates for intracellular delivery of therapeutic oligonucleotides.Front Mol Biosci2026https://conductscience.org/library/papers/41767047PubMed
41726439Machine Learning for Predicting Drug Release Behavior of PLGA Microspheres.AMIA Annu Symp Proc2024https://conductscience.org/library/papers/41726439PubMed
41634507Beyond the dose: a clearance-enabled in vitro platform for evaluating local therapies.Drug Deliv Transl Res2026https://conductscience.org/library/papers/41634507PubMed
41594677Magnetic Nanocarriers with ICPTES- and GPTMS-Functionalized Quaternary Chitosan for pH-Responsive Doxorubicin Release.Biomolecules2026https://conductscience.org/library/papers/41594677PubMed
41583445Covalent organic frameworks for cancer immunotherapy: mechanisms, applications, and prospects.Front Immunol2025https://conductscience.org/library/papers/41583445PubMed
41472401Peptomer Linkers Enable Kinetic Control over Co-Delivery of Multiple Chemotherapeutics.Adv Healthc Mater2026https://conductscience.org/library/papers/41472401PubMed
41471080Development and Antitumor Evaluation of Doxorubicin-Loaded Two-Layered Sheets for Local Chemotherapy via Direct Drug Application to the Tumor Surface.Pharmaceutics2025https://conductscience.org/library/papers/41471080PubMed
41460317Design and characterization of phloretin-loaded PEG-lipid hybrid micelles for enhanced breast cancer therapy.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41460317PubMed
41459545Marine-derived L-asparaginase: unlocking marine power in anti-tumor therapeutics.Front Immunol2025https://conductscience.org/library/papers/41459545PubMed
41426052Synthesis and anticancer potential of glycosides.RSC Adv2025https://conductscience.org/library/papers/41426052PubMed
41369447Therapeutic Potential of Nanoscale Metal-Organic Frameworks in Hepatocellular Carcinoma.Nanomaterials (Basel)2025https://conductscience.org/library/papers/41369447PubMed
41318792Dual-drug codelivery gelatin-based hydrogel of ARV-471 and Palbociclib enhances synergistic effect in breast cancer treatment.Sci Rep2025https://conductscience.org/library/papers/41318792PubMed
41301872Biomimetic Porous Coatings on a Biocompatible Ti-15Mo Alloy as a Platform for Local Delivery of Anticancer Drugs to Patient Tissues.Biomedicines2025https://conductscience.org/library/papers/41301872PubMed

See all 55 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36746307

GET https://conductscience.org/api/papers/v1/36746307/cited_by?page=2